Karyopharm Therapeutics Overview

Karyopharm Therapeutics is an innovation-driven pharmaceutical company focused on the discovery, development, and commercialization of medicines with the goal of improving the lives of patients with cancer.
Founded in 2008, Karyopharm Therapeutics is an established company that loves to hire graduates from Northeastern University, with 30.0% of its employees having attended Northeastern University. Karyopharm Therapeutics has established itself as a great place to work in Massachusetts, and it is number 19 on Zippia's list of Best Companies to Work for in Newton, MA. The average employee at Karyopharm Therapeutics makes $97,763 per year, which is quite competitive for its location and industry. In comparison, some of its highest paying competitors, like Alder BioPharmaceuticals, Cubist Pharmaceuticals, and Parexel, pay $94,068, $92,030, and $85,860, respectively.
Based in Massachusetts, Karyopharm Therapeutics is a small pharmaceutical company with only 108 employees and an annual revenue of $166,000.

The Organization’s Mission

We seek to foster scientific creativity with pioneering technologies and developmental approaches within an innovative culture that will accelerate first-in-class small molecule modulators of nuclear transport into effective therapeutics for life-threatening conditions.


Drug Manufacturers





Founded in



Newton, MA



Organization Type


Is This Your Company?

What do people say about Karyopharm Therapeutics

Work at Karyopharm Therapeutics? Share your experience anonymously.

What do you like about working for Karyopharm Therapeutics?

The Team At Karyopharm Therapeutics

Key People
  • Paul Brannelly (Executive Officer)
  • Sharon Shacham (Executive Officer)
  • Michael Kauffman (Executive Officer, Director)
  • Deepika Pakianathan (Director)
  • Kenneth Weg (Director)
  • Mansoor Mirza (Director)
  • Barry Greene (Director)

Karyopharm Therapeutics Company Rankings

Karyopharm Therapeutics is ranked #46 on the Best Pharmaceutical Companies to Work For in Massachusetts list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Karyopharm Therapeutics Salaries

How much does Karyopharm Therapeutics pay?
The national average salary for a Karyopharm Therapeutics employee in the United States is $97,763 per year. Employees in the top 10 percent can make over $162,000 per year, while employees at the bottom 10 percent earn less than $58,000 per year.
Salary Score
Average Employee Earnings

Karyopharm Therapeutics Salaries By Job Title

While Karyopharm Therapeutics employees earn an average yearly salary of $97,763, different roles can command different wages. The higher paying positions at Karyopharm Therapeutics include senior director, associate medical director, senior manager, and manager, competitive intelligence. A typical senior director salary at Karyopharm Therapeutics is $199,865. To get a better sense of the salaries at Karyopharm Therapeutics, other roles such as administrative assistant and research assistant can be considered as well. For comparison, the title administrative assistant at Karyopharm Therapeutics earns $38,441 per year.
Job Title
Average Salarydesc
Senior Director
Salary Range179k - 222k$200k$199,865
Associate Medical Director
Salary Range131k - 163k$147k$146,515
Senior Manager
Salary Range125k - 146k$135k$135,428
Manager, Competitive Intelligence
Salary Range122k - 141k$132k$131,804
Clinical Trial Manager
Salary Range93k - 123k$108k$107,512
Business Partner
Salary Range95k - 117k$106k$105,501
Salary Range87k - 119k$102k$102,177
Bioinformatics Scientist
Salary Range85k - 114k$99k$98,935
Salary Range83k - 115k$99k$98,507
Salary Range69k - 103k$85k$84,783

Karyopharm Therapeutics Careers

On average, employees at Karyopharm Therapeutics stay with the company for 1.8 years.

Average Length of Employment

Top Employers Before Karyopharm Therapeutics

Top Employers After Karyopharm Therapeutics

Jobs Nearby

Do you Work At Karyopharm Therapeutics?

Help us make this company more transparent.

Karyopharm Therapeutics Financial Performance

Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.


< $5M

Founded in


Organization type


Karyopharm Therapeutics Financing Rounds

DateascdescAmountascdescSecurity Typeascdesc
Aug 1, 2013Equity
May 1, 2013Equity
Nov 5, 2010Equity

How Would You Rate The Company Culture Of Karyopharm Therapeutics?

Have you worked at Karyopharm Therapeutics? Help other job seekers by rating Karyopharm Therapeutics.

Karyopharm Therapeutics Competitors

Competitors of Karyopharm Therapeutics include Alder BioPharmaceuticals, Cubist Pharmaceuticals, and Parexel. The wages at Alder BioPharmaceuticals average higher than the other similar companies, where the median salary is $94,068 per year. Employees at Cubist Pharmaceuticals earn an average of $92,030 per year, and the employees at Parexel earn an average salary of $85,860 per year.
Average Salarydesc
Alder BioPharmaceuticals
Salary Range67k - 130k$94k$94,068
Cubist Pharmaceuticals
Salary Range73k - 115k$92k$92,030
Salary Range69k - 105k$86k$85,860
Hoffmann-LA Roche
Salary Range64k - 105k$82k$82,242
Revance Therapeutics
Salary Range62k - 103k$81k$80,617
Abraxis BioScience
Salary Range60k - 100k$78k$78,082
ICON Development Solutions
Salary Range56k - 102k$76k$75,867
Salary Range55k - 96k$73k$72,803
Salary Range53k - 90k$70k$69,644
Salary Range50k - 95k$70k$69,571

Frequently Asked Questions about Karyopharm Therapeutics

When was Karyopharm Therapeutics founded?

Karyopharm Therapeutics was founded in 2008.

How many Employees does Karyopharm Therapeutics have?

Karyopharm Therapeutics has 108 employees.

How much money does Karyopharm Therapeutics make?

Karyopharm Therapeutics generates $166,000 in revenue.

What industry is Karyopharm Therapeutics in?

Karyopharm Therapeutics is in the drug manufacturers industry.

What is Karyopharm Therapeutics's mission?

Karyopharm Therapeutics's mission statement is "We seek to foster scientific creativity with pioneering technologies and developmental approaches within an innovative culture that will accelerate first-in-class small molecule modulators of nuclear transport into effective therapeutics for life-threatening conditions."

What type of company is Karyopharm Therapeutics?

Karyopharm Therapeutics is a public company.

Who are Karyopharm Therapeutics's competitors?

Karyopharm Therapeutics competitors include Acceleron Pharma, Aerie Pharmaceuticals, Hoffmann-LA Roche, Abraxis BioScience, MacroGenics, Revance Therapeutics, Glaukos, Cubist Pharmaceuticals, ICON Development Solutions, Parexel, Delcath Systems, Alder BioPharmaceuticals, Aptuit, Onconova Therapeutics, GTx, Covance, Omeros, INO Therapeutics, Celldex Therapeutics, Bioanalytical Systems.

Who works at Karyopharm Therapeutics?

Paul Brannelly (Executive Officer)

Sharon Shacham (Executive Officer)

Michael Kauffman (Executive Officer, Director)

Show More

Are You An Executive, HR Leader, Or Brand Manager At Karyopharm Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Updated July 8, 2021

Zippia gives an in-depth look into the details of Karyopharm Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Karyopharm Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Karyopharm Therapeutics. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of Karyopharm Therapeutics and its employees or that of Zippia.

Karyopharm Therapeutics may also be known as or be related to KARYOPHARM THERAPEUTICS INC, Karyopharm Therapeutics, Karyopharm Therapeutics Inc and Karyopharm Therapeutics Inc.